• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA25-90/I16-30
Medical Device Problem Code Material Puncture/Hole (1504)
Health Effect - Clinical Codes Aneurysm (1708); Clinical Endoleak (4843)
Date of Event 11/07/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the type iiib endoleak and aneurysm enlargement are unconfirmed.The additional endovascular procedure is confirmed.This is moderately consistent with the reported adverse event/incident.Device, user, procedure or anatomy relatedness of complaint could not be determined.Procedure related harms could not be determined.No contributing factors for the type iiib endoleak were identified.The final patient status was reported as stable post intervention.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Corrections: b6: relevant tests and lab data has been updated.G3: awareness date has been updated.H6: investigation finding codes: remove code 3233.H6: investigation conclusion codes: remove code 11.
 
Additional Manufacturer Narrative
The device involved in this event will not be returned for evaluation as it remains implanted in the patient.Patient medical records have been requested.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event or Problem Description
The patient was treated for an abdominal aortic aneurysm on (b)(6) 2017 with the implant of an afx2 bifurcated stent graft and an afx vela suprarenal.There was a reintervention completed on (b)(6) 2025 with the implant of an afx vela infrarenal (reported under mfr# 3011063223-2025-00040).On approximately (b)(6) 2025 the follow up computed tomography (ct) revealed an indeterminate type endoleak with aneurysm enlargement.On (b)(6) 2025 the physician elected to treat the patient.Two ovation ix iliac limbs were implanted in the left iliac limb, two ovation ix iliac limbs were implanted in the right iliac limb, and one afx vela extension was implanted proximally.The endoleak was not resolved, there is a type iiib endoleak.An afx2 bifurcated stent graft was implanted to reline the previously implanted device, ballooned and the type iiib endoleak was resolved.The patient left the procedure room in stable condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Common Device Name
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer (Section G)
ENDOLOGIX
2 musick
,
irvine CA 92618
Manufacturer Contact
gary kirchgater
2 musick
,
irvine, CA 92618
8009832284
MDR Report Key23719512
Report Number3011063223-2025-00184
Device Sequence Number10150785
Product Code MIH
UDI-Device Identifier00818009014863
UDI-Public(01)00818009014863(17)180720
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P120006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Health Professional,Company Representative
Initial Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 11/07/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/20/2018
Device Model NumberBEA25-90/I16-30
Device Lot Number1722975011
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 11/07/2025
Supplement Date Received by Manufacturer01/05/2026
Initial Report FDA Received Date12/04/2025
Supplement Report FDA Received Date01/26/2026
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/08/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AFX VELA SUPRARENAL: LOT# 1724800010; AFX VELA SUPRARENAL: LOT# 2680784003
Outcome Attributed to Adverse Event Required Intervention;
Patient Age75 YR
Patient SexFemale
-
-